logoTry Persana

Verantos - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Verantos including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Verantos company logo

High-validity real-world evidence across all therapeutic areas at scale

Verantos is the market leader in high-validity real-world evidence across all therapeutic areas in life sciences.

HeadquartersMenlo Park, United States
Team size51-100
Founded2015

What is Verantos? - Company Overview & Details

Verantos is Verantos is the market leader in high-validity real-world evidence across all therapeutic areas in life sciences. Founded in 2015, the company is headquartered in Menlo Park, United States.

Who Founded Verantos?

Verantos was founded by Dan Riskin.

Who are the Key Executives at Verantos? - Leadership Team

Verantos is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Verantos

Dan RiskinCEO

Chief Technology Officer (CTO) of Verantos

CTO

About Dan Riskin - CEO of Verantos

Dan Riskin serves as the Chief Executive Officer of Verantos, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Verantos Company Details & Key Information

Where is Verantos located?

Verantos is headquartered in Menlo Park, United States.

How many employees does Verantos have?

Verantos has 51-100 employees.

When was Verantos founded?

Verantos was founded in 2015.

Verantos Official Website

How much funding has Verantos raised?

Verantos has raised $1.2 Million across 2 funding rounds. The most recent funding was completed on 2021-01-20.

Funding Overview

Verantos received a grant from the National Science Foundation for research and development on real-world evidence outcomes.

$1.2 Million
Total Funding Raised
2
Funding Rounds
2021-01-20
Latest Round

Verantos Funding History

Grant
2021-01-20
$1.2 Million

Who are the key investors in Verantos?

Verantos is backed by 1 key investors including National Science Foundation. These investors focus on Health data research, Real-world evidence generation sectors.

Verantos Investor Overview

1
Key Investors
2
Focus Areas
0
Notable Investments

Complete List of Verantos Investors

National Science Foundation

Supports innovative scientific research and initiatives.

Investment Focus
Health data research
Real-world evidence generation

What sectors do Verantos investors focus on?

The investors backing Verantos primarily focus on Health data research, Real-world evidence generation sectors.

Health data research
Real-world evidence generation

Featured Investor: National Science Foundation

National Science Foundation

Supports innovative scientific research and initiatives.

Notable Investments:

What are Verantos's future plans?

Future Plans Information Not Available

Detailed information about Verantos's future plans and strategic initiatives is not currently available in our database.

What are the latest news about Verantos?

Verantos has 2 recent news updates covering key business developments and market activities.

Verantos News Overview

2
Recent Articles
Active
Media Coverage
2024-04-30
Latest Update

What is Verantos in the news for?

Verantos is currently featured in news for Verantos launches Inflammatory Bowel Disease Pragmatic Registry. and other significant business developments.

Recent News Articles About Verantos

Article 1
2024-04-30

Verantos launches Inflammatory Bowel Disease Pragmatic Registry.

Verantos has launched a registry to collect real-world data for ulcerative colitis and Crohn's disease patients.

prnewswire.com
Read News
Article 2
2025-03-10

Verantos attended event JAMA Network Open on Mar 10th '25.

Verantos-led study in JAMA Network Open reveals approaches to measure and optimize data reliability.

hrtechwire.com
Read News

Verantos FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Verantos including information about founders, CEO, funding history, investors, headquarters location, and company details. 16 frequently asked questions covering key information about the company.

Verantos Questions & Answers - Company Information

Q1

What is Verantos?

Verantos is the market leader in high-validity real-world evidence across all therapeutic areas in life sciences.

Q2

Who founded Verantos?

Verantos was founded by Dan Riskin.

Q3

Who is the CEO of Verantos?

The CEO of Verantos is Dan Riskin. You can find more information about them on their LinkedIn profile.

Q4

How much funding has Verantos raised?

Verantos has raised a total of $$1.2 Million across 2 funding rounds. The most recent funding was completed on 2021-01-20.

Q5

Who are the investors in Verantos?

Verantos's key investors include National Science Foundation.

Q6

Where is Verantos headquartered?

Verantos is headquartered in Menlo Park, United States.

Q7

When was Verantos founded?

Verantos was founded in 2015.

Q8

How many employees does Verantos have?

Verantos has 51-100 employees.

Q9

What is Verantos's official website?

You can visit Verantos's official website at verantos.com.

Q10

What was Verantos's latest funding round?

Verantos's latest funding round was a Grant round of $$1.2 Million completed on 2021-01-20.

Q11

Who is founder?

Dan Riskin

Q12

What does the company do?

Verantos is the market leader in high-validity real-world evidence across all therapeutic areas in life sciences.

Q13

How much funding?

$1.2 Million

Q14

Latest funding date?

2021-01-20

Q15

Who are the investors?

National Science Foundation

Q16

Latest news?

Verantos has launched a registry to collect real-world data for ulcerative colitis and Crohn's disease patients. Verantos-led study in JAMA Network Open reveals approaches to measure and optimize data reliability.

More Information About Verantos

For additional details about Verantos, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.